Refine your search
3 trials found for Transthyretin amyloid cardiomyopathy, Transthyretin amyloidosis cardiomyopathy
All(3)
Recruiting(2)
Not yet recruiting(1)
Recruiting
NCT06086353
A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India
Transthyretin Amyloid Cardiomyopathy
Male or Female
18+ years
2study location(s)
Recruiting
NCT04801329
Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Male or Female
19+ years
1study location(s)
Oct 28, 2024 - Planned start date (Not yet recruiting)
nct06651073
attr-cm: a multi-country, non-interventional disease registry
transthyretin amyloid cardiopathy
all
18+ years
1study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
All(3)
Recruiting(2)
Not yet recruiting(1)
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.